NCT01127516View on ClinicalTrials.gov

The Causes and Interpretation of Low-level Resistance in Staphylococcus Aureus

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Staphylococcus Aureus
Trial Locations (1)

23298

Virginia Commonwealth University School ofPharamcy, Richmond

Sponsors

Collaborators (1)

Astellas Pharma Inc
All Listed Sponsors
collaborator

Astellas Pharma Inc

INDUSTRY

lead

Virginia Commonwealth University

OTHER